Literature DB >> 8993514

Treatment of central nervous system xenografts with camptothecins.

H S Friedman1, P J Houghton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8993514     DOI： 10.1111/j.1749-6632.1996.tb26390.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.

Authors:  P A Burch; A M Bernath; T L Cascino; B W Scheithauer; P Novotny; S Nair; J C Buckner; D M Pfeifle; J W Kugler; L K Tschetter
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

2.  Antitumoral effect of irinotecan (CPT-11) on an experimental model of malignant neuroectodermal tumor.

Authors:  C Morales; M Zurita; J Vaquero
Journal:  J Neurooncol       Date:  2002-02       Impact factor: 4.130
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.